Gout and Uric Acid After 40: The <6.0 mg/dL Target and Thai Safety Check

After age forty, gout should not be seen only as “joint pain that needs a painkiller.” In this evidence bundle, hyperuricemia is identified as the main physiological driver of gout in men aged 40 and older, and reaching a serum urate target has long-term meaning for joints, kidneys, and cardiovascular outcomes.

This article is not telling you to start or adjust medication yourself. It is meant to help you talk with your doctor more clearly: what the target is, why Thai adults need to consider genetic safety before allopurinol, and why diet or supplements should not be sold as a substitute for standard gout care.

Three-Line Summary

1. Major clinical guidelines recommend a treat-to-target strategy, keeping serum urate below 6.0 mg/dL to help prevent joint damage and systemic complications.
2. For Thai adults, HLA-B*58:01 testing before allopurinol is a cost-effective preventive strategy that reduces life-threatening severe cutaneous adverse reactions.
3. Evidence for diet or supplements, such as purine restriction, vitamin C, or cherry juice, remains weak and inconclusive compared with standard therapies.

High Uric Acid Is the Core Driver of Gout

The evidence bundle states that in men aged 40 and older, hyperuricemia, or elevated blood uric acid, is the primary physiological driver of gout. This means gout care should not stop at suppressing sudden pain.

If you have gout, the important question is not only “Does it hurt today?” It is whether serum urate is being monitored and brought to target, because gout has a long-term picture involving joints and systemic complications.

⚠️ Caveat: the evidence bundle does not provide diagnostic criteria, detailed symptom lists, or instructions for interpreting blood tests by yourself. This article should not be used to self-diagnose gout from a lab value or joint pain alone.

The Below-6.0 mg/dL Target: Treating to Prevent Joint Damage

The 2020 American College of Rheumatology guideline recommends a treat-to-target strategy to keep serum urate below 6.0 mg/dL. The purpose is to help prevent joint damage and systemic complications.

This number matters because it gives gout care a measurable target. Care is not only about treating pain on the day it appears and forgetting the condition when the pain improves. Reaching the target should be managed by a doctor, especially if kidney disease, cardiovascular disease, or other medications are part of the picture.

For adults 40+, the safe step is to ask your doctor what your serum urate target is, whether you are at that target now, and how it should be followed. Do not increase, decrease, or buy medication on your own based on a number in an article.

Thai Adults and HLA-B*58:01 Before Allopurinol

A 2025 economic evaluation in Thailand reported that HLA-B*58:01 genetic testing before allopurinol in Thai patients with gout is a cost-effective preventive strategy and reduces allopurinol-induced severe cutaneous adverse reactions, or SCARs, which can be life-threatening.

This is directly relevant to the Thai context. If your doctor is considering allopurinol, asking about HLA-B*58:01 is not excessive worry. It is a safety conversation before starting medication.

⚠️ Caveat: this article does not say who should or should not receive allopurinol, and it does not explain how to act on a genetic test result. Medication and testing decisions should be made with a doctor.

Diet, Supplements, and Cherry Juice: Evidence Is Still Uncertain

A 2025 systematic review of randomized controlled trials concluded that clinical evidence for dietary changes or supplements to lower uric acid or prevent gout flares remains weak and inconclusive compared with standard pharmacological therapies.

The examples named in the evidence bundle are purine restriction, vitamin C, and cherry juice. None of these should be presented as a replacement for standard care or as a guaranteed way to lower uric acid and prevent gout attacks.

The risk is advertising that persuades people to stop following serum urate or delay medical care. In this topic, the evidence strength for diet and supplements is explicitly weak and inconclusive.

During a Flare: Medication Choice Depends on Patient Risk

For acute gout attacks, the evidence bundle states that low-dose colchicine, NSAIDs, and oral corticosteroids show comparable clinical efficacy for pain reduction.

The key difference is not “which drug is strongest.” It is the patient’s cardiovascular and renal risk profile, because medication choice should be determined by individual risk.

⚠️ Caveat: if you have kidney disease, cardiovascular disease, take multiple medications, or have had problems with pain medicines before, do not choose a drug from this article. Consult a doctor or pharmacist.

Kidneys, Heart, and the Overall Evidence Picture

Long-term cohort data in the evidence bundle indicate that achieving and maintaining target serum urate is associated with a significantly reduced risk of chronic kidney disease progression and major adverse cardiovascular events in patients with gout.

The word “associated” matters. Cohort data help show long-term outcome patterns, but they should not be turned into an overpromise that one number will definitely prevent kidney or heart disease for every individual.

Topic	What the evidence bundle says	Confidence for readers
Serum urate target	Guidelines recommend treat-to-target below 6.0 mg/dL	Strong within guideline context
HLA-B*58:01 in Thailand	Testing before allopurinol is cost-effective and reduces life-threatening SCARs	Strong for the Thai context in economic evaluation
Diet and supplements	Purine restriction, vitamin C, and cherry juice remain weak and inconclusive	Limited
Medication during acute pain	Low-dose colchicine, NSAIDs, and oral corticosteroids have comparable pain-reduction efficacy	Strong within the overall evidence bundle, but patient risk determines choice
Kidneys and heart	Reaching serum urate target is associated with lower CKD progression and MACE	Strong for long-term association, not a personal guarantee

Overall, this evidence bundle is strong because it includes clinical practice guidelines, a systematic review of randomized controlled trials, and large-scale cohort evidence. Some questions, especially diet, supplements, and individual mechanisms, still need cautious wording.

What to Discuss With a Doctor

If you have gout or suspect gout, ask your doctor about the serum urate target below 6.0 mg/dL, where your current level stands, how it should be followed, and whether kidney or cardiovascular risks affect medication choice.

If you are about to start allopurinol or have a history of medication reactions, ask about HLA-B*58:01, especially in the Thai context. During an acute flare, let a doctor or pharmacist help choose medication based on your risks instead of choosing on your own because several options reduce pain similarly.

Diet still matters for overall health. But from this evidence bundle, purine restriction, vitamin C, and cherry juice should not replace standard gout monitoring and treatment.

This article is for understanding, not personal medical advice. Testing, interpretation, and medication decisions should be made with the doctor or qualified professional who cares for you.